Old Red Blood Cell In Renal Transplantation

NCT02841111 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2016-07-22

No results posted yet for this study

Summary

Kidney transplantation is the treatment of choice for ESRD. However, the life expectancy of kidney transplant patients is lower than that of the general population. Deaths recipients are due mainly to cardiovascular diseases related to a chronic inflammatory state. In addition, renal transplant patients frequently have anemia, identified as an independent cardiovascular risk factor that can be corrected by blood transfusion.

But the relationship between transfusion and inflammatory condition are bidirectional. The patient's inflammatory condition will sound on the effectiveness of transfusion and transfusion could trigger an inflammatory condition. This has been reported with the said blood components "aged", especially with packed red cells in patients hospitalized in intensive care after heavy heart surgery.The main objective of this study is to evaluate the impact of early transfusions on the evolution of renal transplantation (ie death, anti-HLA immunization, acute rejection, graft loss, delayed graft function, cardiovascular events ) taking into account in the analysis: patient age at the time of transplantation, the number of incompatibility (s) (HLA class I and / or II) between the graft and the patient and sex of the recipient.

This is a multicenter retrospective observational study (descriptive epidemiological study).The impact of early transfusions is determined retrospectively over a period of 6 years from 01 January 2002 to 31 December 2008, in renal transplant patients of all centers of France met the criteria for inclusion. This cohort represents about 12 000-14 000 patients

Conditions

  • Disorder Related to Renal Transplantation
  • Transfusion Reaction

Sponsors & Collaborators

  • Agence de La Biomédecine

    collaborator OTHER_GOV
  • Etablissement Français du Sang

    collaborator OTHER
  • Amiens University Hospital

    collaborator OTHER
  • University Hospital, Angers

    collaborator OTHER_GOV
  • Bicetre Hospital

    collaborator OTHER
  • University Hospital, Bordeaux

    collaborator OTHER
  • University Hospital, Brest

    collaborator OTHER
  • University Hospital, Caen

    collaborator OTHER
  • University Hospital, Clermont-Ferrand

    collaborator OTHER
  • CRC CHI Creteil France

    collaborator OTHER_GOV
  • Centre Hospitalier Universitaire Dijon

    collaborator OTHER
  • Hopital Foch

    collaborator OTHER
  • University Hospital, Grenoble

    collaborator OTHER
  • Groupe Hospitalier Pitie-Salpetriere

    collaborator OTHER
  • University Hospital, Lille

    collaborator OTHER
  • University Hospital, Limoges

    collaborator OTHER
  • Hôpital Edouard Herriot

    collaborator OTHER
  • Centre Hospitalier Lyon Sud

    collaborator OTHER
  • University Hospital, Marseille

    collaborator OTHER
  • University Hospital, Montpellier

    collaborator OTHER
  • Central Hospital, Nancy, France

    collaborator OTHER
  • Nantes University Hospital

    collaborator OTHER
  • Hôpital Necker-Enfants Malades

    collaborator OTHER
  • Centre Hospitalier Universitaire de Nice

    collaborator OTHER
  • Poitiers University Hospital

    collaborator OTHER
  • CHU de Reims

    collaborator OTHER
  • Rennes University Hospital

    collaborator OTHER
  • CHU de Rouen - Accueil

    collaborator OTHER
  • Centre Hospitalier Universitaire de Saint Etienne

    collaborator OTHER
  • Saint-Louis Hospital, Paris, France

    collaborator OTHER
  • University Hospital, Strasbourg, France

    collaborator OTHER
  • Tenon Hospital, Paris

    collaborator OTHER
  • University Hospital, Toulouse

    collaborator OTHER
  • University Hospital, Tours

    collaborator OTHER
  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2008-12-31
Completion
2008-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02841111 on ClinicalTrials.gov